Increased Systemic Immune-Inflammation Index as a Novel Indicator of Alzheimer’s Disease Severity

17Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Inflammatory processes and neurodegeneration are common features of Alzheimer's disease (AD). The systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are easily accessible, cost-effective prognostic indicators of inflammation status. We assessed the diagnostic value of SII and compared the efficacies of NLR, PLR, and SII in predicting AD severity. Materials and Methods: Between January 2021 and December 2022, this prospective, cross-sectional clinical study included 175 patients with AD and 61 controls. SII, NLR, and PLR were calculated. Results: Age, white blood cell and lymphocyte counts, and NLR and PLR values were significantly different between the patient and control groups (P

Cite

CITATION STYLE

APA

Algul, F. E., & Kaplan, Y. (2025). Increased Systemic Immune-Inflammation Index as a Novel Indicator of Alzheimer’s Disease Severity. Journal of Geriatric Psychiatry and Neurology, 38(3), 214–222. https://doi.org/10.1177/08919887241280880

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free